These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4595022)

  • 1. [Placebo effect in psychopharmacotherapy with special reference to Mepiprazol effect in excitatory conditions of patients with psychoses].
    Gonçalves N
    Med Welt; 1974 Mar; 25(10):420-3. PubMed ID: 4595022
    [No Abstract]   [Full Text] [Related]  

  • 2. [Performance in attention tests in chronic schizophrenics treated with Mepiprazol (author's transl)].
    Gonçalves N; Fieguth G
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):167-77. PubMed ID: 4603734
    [No Abstract]   [Full Text] [Related]  

  • 3. The prediction of placebo effect in functional psychoses.
    Vinarová E; Vinar O
    Act Nerv Super (Praha); 1973 Mar; 15(1):53-4. PubMed ID: 4572683
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial with Sulpiride and placebo in chronic schizophrenics (study of 89 patients using the Harris-Letemendía-Willems scale)].
    Mezquita Blanco J; Cubillo Sánchez J; Aizpiri Díaz J; Zubia Zubia B
    Arch Neurobiol (Madr); 1972; 35(5):453-72. PubMed ID: 4568565
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxypertine in the treatment of schizophrenia.
    Alapin B; Golebiewska M
    Act Nerv Super (Praha); 1967 Nov; 9(4):436-9. PubMed ID: 4889080
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of tybamate in psychotic patients. (A further double blind study).
    Meshel E; Denber HC
    Dis Nerv Syst; 1968 Apr; 29(4):243-5. PubMed ID: 4870945
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K; Fullerton AG; Hussain K; Tarlo L
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiothixene in schizophrenic psychoses.
    Vinar O; Taussigová D; Bastecký J
    Act Nerv Super (Praha); 1971; 13(3):174-7. PubMed ID: 4939830
    [No Abstract]   [Full Text] [Related]  

  • 12. A multicentric clinical evaluation of pimozide. Preliminary report.
    Brugmans J
    Acta Neurol Psychiatr Belg; 1968; 68(12):875-87. PubMed ID: 4976735
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychopharmacological experiences with methophenazine with particular reference to Leonhard's classification of endogenous psychoses].
    Neumann J; Schulze HA
    Psychiatr Neurol Med Psychol (Leipz); 1966 Jan; 18(1):11-7. PubMed ID: 4862323
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxypertine in schizophrenic psychoses. Controlled clinical trial in two psychiatric hospitals.
    Vinar O; Hamouz V; Bastecký J
    Act Nerv Super (Praha); 1968 Oct; 10(3):315-7. PubMed ID: 4883240
    [No Abstract]   [Full Text] [Related]  

  • 15. A double blind study of clomacran.
    Lampe WT
    Curr Ther Res Clin Exp; 1969 May; 11(5):300-6. PubMed ID: 4977403
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychopharmacologic contribution to the clinical use of a psychosedative].
    Pernhaupt G; Quatember R
    Wien Med Wochenschr; 1970 Oct; 120(42):737-40. PubMed ID: 4926115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of haloperidol and penfluridol on the learning capacity of the schizophrenic.
    Van Lommel R; Baro F; Dom R
    Arzneimittelforschung; 1974 Jul; 24(7):1072-4. PubMed ID: 4605278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.